Tradestie Institutional Equity Comparison Engine
THOR vs ICUI โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
ICUI Overall Edge
ICUI Captures Institutional Edge (4โ0 Pillars ยท 9โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to ICU Medical Inc (ICUI) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, THOR trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus ICUI at 17.8x Forward P/E and 6.7% operating margin (+4.4% YoY). In options structure, THOR sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against ICUI sits in UNCLASSIFIED (2nd %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
ICUI
THOR N/M vs ICUI 17.8x Fwd P/E
Growth & Margin Winner
ICUI
Op Margin N/A vs 6.7% ยท YoY N/A vs +4.4%
Momentum & Technical Winner
ICUI
1Y -1.4% vs +30.1% ยท 52W Pos 2% vs 74%
Options & Structure Winner
ICUI
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (2nd %ile IV)
THOR
US Equity
THOR
Institutional Equity
$24.63
-1.7% 1D
Market Cap
N/A
1M Return
-3.92%
1Y Return
-1.43%
Forward P/E
N/M
Unified AI Score
44.5 / 100
HOLD
Tech 27.0
Fund 50.0
Flow 50.0
Mom 60.0
ICUI
NASDAQ
ICU Medical Inc
Surgical & Medical Instruments & Apparatus
$172.52
-1.84% 1D
Market Cap
$4.4B
1M Return
+2.49%
1Y Return
+30.14%
Forward P/E
17.8x
Unified AI Score
49.5 / 100
HOLD
Tech 45.0
Fund 47.0
Flow 50.0
Mom 50.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
THOR -1.43%
ICUI +30.14%
Spread: +28.73 pp (ICUI Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
THOR TTM Op. Margin: N/A
ICUI TTM Op. Margin: 6.7%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on THOR vs ICUI. Trailing 12-month operating profitability (THOR N/A vs ICUI 6.7%) and valuation multiples (THOR N/M vs ICUI 17.8x Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | THOR | ICUI | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | N/A | $4.4B | Larger Scale | ICUI |
| Trailing P/E Ratio Valuation | N/M | 73.5x | Lower Multiple | ICUI |
| Forward P/E Ratio Valuation | N/M | 17.8x | Lower Multiple | ICUI |
| Revenue Growth (YoY) Growth | N/A | +4.4% | Higher Growth | ICUI |
| Operating Margin (TTM) Profitability | N/A | 6.7% | Higher Margin | ICUI |
| Net Profit Margin Profitability | N/A | 2.8% | Higher Margin | ICUI |
| Return on Equity (ROE) Capital Efficiency | N/A | 2.8% | Higher ROE | ICUI |
| 52-Week Range Position Momentum | 2% ($25โ$29) | 74% ($113โ$193) | Stronger Trend | ICUI |
| Beta / 30D Volatility Risk Regime | 0.46ฮฒ ยท 17% Vol | 0.86ฮฒ ยท 38% Vol | Lower Realized Risk | THOR |
| Unified Institutional Score Composite Signal | 44.5 / 100 (HOLD) | 49.5 / 100 (HOLD) | Higher Composite | ICUI |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full THOR vs ICUI Buy Guide
THOR
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
ICUI
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
2nd %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither THOR nor ICUI registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.